Edwards Lifescns Rg
EW
USD
STOCK MARKET:
NYX
Closed
 
...
Large gap with delayed quotes
Official
07/25/2026 - 02:04:00
Bid
07/24/2026 - 22:00:00
Bid
Volume
Ask
07/24/2026 - 22:00:00
Ask
Volume
82.63
-1.19 ( -1.42% )
82.67
23,200
82.68
100
More information
Analysis by TheScreener
21.07.2026
Evaluation Neutral  
Interest None  
Sensibility Low  
Analysis date: 21.07.2026
Global Evaluation
  Neutral
The stock is classified in the neutral zone since 17.07.2026.
Interest
  None
No stars since 17.07.2026.
Earnings Rev Trend
  Negative
 
Compared to seven weeks ago, the analysts have lowered their earnings per share estimates. This negative trend began 10.07.2026 at a price of 92.21.
Evaluation
  Overvalued
 
Based on its growth potential and our own criteria, we believe the share price is currently moderately overvalued.
MT Tech Trend
  Negative
 
The dividend-adjusted forty day technical trend is negative since 17.07.2026.
4wk Rel Perf
  -3.33%
 
The four-week dividend-adjusted underperformance versus SP500 is 3.33%.
Sensibility
  Low
Low, no change over 1 year.
Bear Market Factor
  Low
On average, the stock has a tendency to minimize the drops in the index by -0.38%.
Bad News Factor
  Low
When the stock's pressure is specific, the market sanction on average is 2.43%.
Mkt Cap in $bn
  48.94
With a market capitalization >$8bn, EDWARDS LIFESCIENCES is considered a large-cap stock.
G/PE Ratio
  0.84
A ratio (Forecasted Growth + Estimated Dividend Yield/ Estimated Price Earnings) below 0.9 indicates that investors must pay a premium for the estimated growth potential: premium.
LT P/E
  22.29
The estimated PE is for the year 2028.
LT Growth
  18.75%
The annualized growth estimate is for the current year to 2028.
Avg. Nb analysts
  23
Over the last seven weeks, an average of 23 analysts provided earnings per share estimates.
Dividend Yield
  0.00%
The company is not paying a dividend.
Beta
  69
For 1% of index variation, the stock varies on average by 0.69%.
Correlation
  0.34
Stock movements are strongly independent of index variations.
Value at Risk
  10.15
The value at risk is estimated at USD 10.15. The risk is therefore 12.00%. This value is based on the historical volatility for a medium time period (1 month) with a confidence of 95%.
First Analysis Date
  02.01.2002